These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30843624)

  • 1. The platelet-derived growth factor receptor alpha promoter-directed expression of cre recombinase in mouse placenta.
    Wattez JS; Qiao L; Lee S; Natale DRC; Shao J
    Dev Dyn; 2019 May; 248(5):363-374. PubMed ID: 30843624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Tissue-Specific Recombination in a Pdgfrα-CreERT2 Transgenic Mouse Line.
    O'Rourke M; Cullen CL; Auderset L; Pitman KA; Achatz D; Gasperini R; Young KM
    PLoS One; 2016; 11(9):e0162858. PubMed ID: 27626928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of PDGFRα-GFPCreERT2 knock-In mouse line.
    Miwa H; Era T
    Genesis; 2015 May; 53(5):329-36. PubMed ID: 25884589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
    Xu J; Yao G; Ru Y; Xie S
    Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-independent recombination in the RIP-CreER mouse.
    Liu Y; Suckale J; Masjkur J; Magro MG; Steffen A; Anastassiadis K; Solimena M
    PLoS One; 2010 Oct; 5(10):e13533. PubMed ID: 21063464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.
    Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D
    Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted expression of Cre recombinase provokes placental-specific DNA recombination in transgenic mice.
    Zhou CC; Chang J; Mi T; Abbasi S; Gu D; Huang L; Zhang W; Kellems RE; Schwartz RJ; Xia Y
    PLoS One; 2012; 7(2):e29236. PubMed ID: 22363401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGFRβ-P2A-CreER
    Cuervo H; Pereira B; Nadeem T; Lin M; Lee F; Kitajewski J; Lin CS
    Angiogenesis; 2017 Nov; 20(4):655-662. PubMed ID: 28752390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
    Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
    Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo.
    Yadav D; Conner JA; Wang Y; Saunders TL; Ubogu EE
    Vascul Pharmacol; 2024 Jun; 155():107369. PubMed ID: 38554988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal induction of Cre recombination with tamoxifen.
    Lizen B; Claus M; Jeannotte L; Rijli FM; Gofflot F
    Transgenic Res; 2015 Dec; 24(6):1065-77. PubMed ID: 26395370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fidelity
    Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
    Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.
    Kilani B; Gourdou-Latyszenok V; Guy A; Bats ML; Peghaire C; Parrens M; Renault MA; Duplàa C; Villeval JL; Rautou PE; Couffinhal T; James C
    J Thromb Haemost; 2019 May; 17(5):827-840. PubMed ID: 30801958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
    Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
    Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporally controlled somatic mutagenesis in smooth muscle.
    Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
    Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible Cre mice.
    Feil S; Valtcheva N; Feil R
    Methods Mol Biol; 2009; 530():343-63. PubMed ID: 19266339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic inducible fate mapping in adult mice using tamoxifen-dependent Cre recombinases.
    Feil S; Krauss J; Thunemann M; Feil R
    Methods Mol Biol; 2014; 1194():113-39. PubMed ID: 25064100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.